Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Eagle Pharmaceuticals (EGRX)

Eagle Pharmaceuticals (EGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Eagle Announces Update on Delisting from Nasdaq and SEC Deregistration GlobeNewswire - Fri Nov 15, 4:00PM CST

EGRX : 0.5800 (+5.45%)
Eagle Pharmaceuticals Appoints Christopher Krawtschuk as Chief Financial Officer GlobeNewswire - Tue Nov 12, 6:00AM CST

EGRX : 0.5800 (+5.45%)
Eagle Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan GlobeNewswire - Thu Oct 31, 7:00AM CDT

EGRX : 0.5800 (+5.45%)
Eagle Pharmaceuticals: Q2 Earnings Snapshot AP - Tue Aug 8, 2023

Eagle Pharmaceuticals: Q2 Earnings Snapshot

EGRX : 0.5800 (+5.45%)
Eagle Pharmaceuticals: Q1 Earnings Snapshot AP - Tue May 9, 2023

Eagle Pharmaceuticals: Q1 Earnings Snapshot

EGRX : 0.5800 (+5.45%)
Eagle Pharmaceuticals: Q4 Earnings Snapshot AP - Mon Mar 13, 2023

Eagle Pharmaceuticals: Q4 Earnings Snapshot

EGRX : 0.5800 (+5.45%)
Eagle Pharmaceuticals: Q3 Earnings Snapshot AP - Mon Nov 7, 2022

Eagle Pharmaceuticals: Q3 Earnings Snapshot

EGRX : 0.5800 (+5.45%)
Eagle Pharmaceuticals (EGRX) Q2 2022 Earnings Call Transcript Motley Fool - Tue Aug 9, 2022

EGRX earnings call for the period ending June 30, 2022.

EGRX : 0.5800 (+5.45%)
Eagle Pharmaceuticals Reports Second Quarter 2022 Results Globe Newswire - Tue Aug 9, 2022

•   Q2 2022 net loss was $(0.74) per basic and diluted share and adjusted non-GAAP net income was $1.58 per basic and $1.56 per diluted share •   Total...

EGRX : 0.5800 (+5.45%)
Eagle Pharmaceuticals Takes Equity Stake in, with Option to Acquire, Enalare Therapeutics to Advance Global Development of ENA-001, a Novel Agnostic Respiratory Stimulant Globe Newswire - Tue Aug 9, 2022

-- ENA-001 is currently in development for: post-operative respiratory depression, community drug overdose, and Apnea of Prematurity -- -- Approval for...

EGRX : 0.5800 (+5.45%)

Barchart Exclusives

3 Pharma Stocks to Buy as California Sounds the Alarm on Bird Flu Cases Barchart - 1 hour ago
The bird flu crisis is creating investment opportunities in the pharmaceutical sector, with Sanofi, GSK, and CSL Limited emerging as top picks. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot